Publication:
Hepatitis E Infection in HIV-Infected Patients.

dc.contributor.authorRivero-Juarez, Antonio
dc.contributor.authorLopez-Lopez, Pedro
dc.contributor.authorFrias, Mario
dc.contributor.authorRivero, Antonio
dc.contributor.funderMinistry of Economy and Competitiveness
dc.contributor.funderEuropean Regional Development Fund
dc.contributor.funderInstitute of Health Carlos III (ISCIII)
dc.contributor.funderSPANISH AIDS Research Network
dc.contributor.funderMinisterio de Ciencia, Promoción y Universidades of Spain.
dc.date.accessioned2023-01-25T13:36:38Z
dc.date.available2023-01-25T13:36:38Z
dc.date.issued2019-06-05
dc.description.abstractThe hepatitis E virus (HEV) represents a major cause of acute hepatitis worldwide. The majority of HEV cases occur in low-income countries, mainly Asia and Africa, where HEV causes large outbreaks associated with the consumption of contaminated water and high mortality in specific populations. In high-income countries, HEV infection is considered a zoonotic disease that is linked to the consumption of contaminated food. Although a high proportion of cases have self-limiting asymptomatic or subclinical infections, immunosuppression may modify the pathogenesis and clinical impact of this emerging disease. Here, we review the current knowledge about the epidemiology, diagnosis, clinical manifestations, management and prevention of HEV infection in HIV-infected subjects. Despite the increasing knowledge about the pathogenesis, epidemiology and clinical impact of HEV infection, several major factors are faced by HIV-infected patients, including treatment recommendations, immunization and risk practices.
dc.description.versionSi
dc.identifier.citationRivero-Juarez A, Lopez-Lopez P, Frias M, Rivero A. Hepatitis E Infection in HIV-Infected Patients. Front Microbiol. 2019 Jun 26;10:1425
dc.identifier.doi10.3389/fmicb.2019.01425
dc.identifier.issn1664-302X
dc.identifier.pmcPMC6608679
dc.identifier.pmid31297100
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608679/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fmicb.2019.01425/pdf
dc.identifier.urihttp://hdl.handle.net/10668/14237
dc.journal.titleFrontiers in microbiology
dc.journal.titleabbreviationFront Microbiol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number1425
dc.publisherFrontiers Research Foundation
dc.pubmedtypeJournal Article
dc.relation.projectIDRD12/0017/0012
dc.relation.projectIDPI16/01297
dc.relation.projectIDCP18/00111
dc.relation.projectIDCD18/00091
dc.relation.publisherversionhttps://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.01425/full
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectHEV
dc.subjectHIV
dc.subjectDiagnosis
dc.subjectEpidemiology
dc.subjectPrevention
dc.subjectTreatment
dc.subjectZoonoses
dc.subject.decsInfecciones asintomáticas
dc.subject.decsInfecciones por VIH
dc.subject.decsInmunización
dc.subject.decsPaíses desarrollados
dc.subject.decsTerapia de inmunosupresión
dc.subject.decsVirus de la Hepatitis E
dc.subject.decsZoonosis
dc.subject.meshHepatitis E virus
dc.subject.meshAsymptomatic infections
dc.subject.meshDeveloped countries
dc.subject.meshZoonoses
dc.subject.meshImmunosuppression therapy
dc.subject.meshImmunization
dc.subject.meshHIV infections
dc.titleHepatitis E Infection in HIV-Infected Patients.
dc.typeResearch article
dc.type.hasVersionVoR
dc.volume.number10
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC6608679.pdf
Size:
1 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Rivero-Juarez_HepatitisE_MaterialSuplementario.docx
Size:
27.77 KB
Format:
Microsoft Word XML